Population Pharmacokinetic and Pharmacodynamic Modeling of Pegvisomant in Asian and Western Acromegaly Patients
Author:
Publisher
Wiley
Subject
Pharmacology (medical),Pharmacology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1177/0091270010386954/fullpdf
Reference32 articles.
1. Growth hormone receptor antagonists: discovery, development, and use in patients with acromegaly;Kopchick;Endocr Rev,2002
2. A consensus on criteria for cure of acromegaly;Giustina;J Clin Endocrinol Metab,2010
3. Guidelines for acromegaly management: an update;Melmed;J Clin Endocrinol Metab,2009
4. Rational design of potent antagonists to the human growth hormone receptor;Fuh;Science,1992
5. The human growth hormone antagonist B2036 does not interact with the prolactin receptor;Goffin;Endocrinology,1999
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. More than a decade of real-world experience of pegvisomant for acromegaly: ACROSTUDY;European Journal of Endocrinology;2021-10-01
2. Long-Acting Human Growth Hormone Receptor Antagonists Produced in E. coli and Conjugated with Polyethylene Glycol;Bioconjugate Chemistry;2020-05-19
3. What is the efficacy of switching to weekly pegvisomant in acromegaly patients well controlled on combination therapy?;European Journal of Endocrinology;2016-05
4. Long-Term Efficacy and Safety of Pegvisomant in Combination With Long-Acting Somatostatin Analogs in Acromegaly;The Journal of Clinical Endocrinology & Metabolism;2014-10-01
5. Circulating levels of pegvisomant and endogenous growth hormone during prolonged pegvisomant therapy in patients with acromegaly;Clinical Endocrinology;2013-06-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3